Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M Al-Shaer, LH Nazer… - Annals of …, 2014 - journals.sagepub.com
Objective: To evaluate the available evidence regarding the efficacy and safety of rifampicin,
as adjunct to colistin, in the treatment of multidrug resistant Acinetobacter baumannii (MDR …
被引用次数：24 相关文章

Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumannii.

M Al-Shaer, LH Nazer, M Kherallah - The Annals of …, 2014 - europepmc.org
Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter
baumannii. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumannii

M Al-Shaer, LH Nazer… - The Annals of …, 2014 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the available evidence regarding the efficacy and safety of rifampicin,
as adjunct to colistin, in the treatment of multidrug resistant Acinetobacter baumannii (MDR …

[引用][C] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M AL-SHAER, LH NAZER… - The Annals of …, 2014 - pascal-francis.inist.fr
Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant
Acinetobacter baumannii CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF] psu.edu

[PDF][PDF] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M Kherallah - Annals of Pharmacotherapy, 2014 - Citeseer
Background A baumannii is a Gram-negative coccobacillus that has emerged recently as an
important and serious cause of health care associated infections. It can survive on surfaces …
[PDF] researchgate.net

[PDF][PDF] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M Kherallah - Annals of Pharmacotherapy, 2014 - researchgate.net
Background A baumannii is a Gram-negative coccobacillus that has emerged recently as an
important and serious cause of health care associated infections. It can survive on surfaces …

Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumannii.

M Al-Shaer, LH Nazer, M Kherallah - 2014 - cabidigitallibrary.org
Objective: To evaluate the available evidence regarding the efficacy and safety of rifampicin,
as adjunct to colistin, in the treatment of multidrug resistant Acinetobacter baumannii (MDR …
[PDF] psu.edu

[PDF][PDF] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M Kherallah - Annals of Pharmacotherapy, 2014 - Citeseer
Background A baumannii is a Gram-negative coccobacillus that has emerged recently as an
important and serious cause of health care associated infections. It can survive on surfaces …

[引用][C] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii

M AL-SHAER, LH NAZER, M KHERALLAH - The Annals of …, 2014 - Whitney